Literature DB >> 19565127

Apocalypse or redemption: responding to extensively drug-resistant tuberculosis.

Ross Upshur1, Jerome Singh, Nathan Ford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19565127      PMCID： PMC2686205          DOI： 10.2471/blt.08.051698

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  4 in total

1.  XDR-TB: entering the post-antibiotic era?

Authors:  Mario Raviglione
Journal:  Int J Tuberc Lung Dis       Date:  2006-11       Impact factor: 2.373

2.  Comprehensive treatment of extensively drug-resistant tuberculosis.

Authors:  Carole D Mitnick; Sonya S Shin; Kwonjune J Seung; Michael L Rich; Sidney S Atwood; Jennifer J Furin; Garrett M Fitzmaurice; Felix A Alcantara Viru; Sasha C Appleton; Jaime N Bayona; Cesar A Bonilla; Katiuska Chalco; Sharon Choi; Molly F Franke; Hamish S F Fraser; Dalia Guerra; Rocio M Hurtado; Darius Jazayeri; Keith Joseph; Karim Llaro; Lorena Mestanza; Joia S Mukherjee; Maribel Muñoz; Eda Palacios; Epifanio Sanchez; Alexander Sloutsky; Mercedes C Becerra
Journal:  N Engl J Med       Date:  2008-08-07       Impact factor: 91.245

3.  XDR-TB in South Africa: no time for denial or complacency.

Authors:  Jerome Amir Singh; Ross Upshur; Nesri Padayatchi
Journal:  PLoS Med       Date:  2007-01       Impact factor: 11.069

4.  International Monetary Fund programs and tuberculosis outcomes in post-communist countries.

Authors:  David Stuckler; Lawrence P King; Sanjay Basu
Journal:  PLoS Med       Date:  2008-07-22       Impact factor: 11.069
  4 in total
  5 in total

1.  The political and ethical challenge of multi-drug resistant tuberculosis.

Authors:  Chris Degeling; Christopher Mayes; Wendy Lipworth; Ian Kerridge; Ross Upshur
Journal:  J Bioeth Inq       Date:  2015-01-29       Impact factor: 1.352

2.  Effects of ascent to high altitude on human antimycobacterial immunity.

Authors:  Sarah Eisen; Louise Pealing; Robert W Aldridge; Mark J Siedner; Alejandro Necochea; Inna Leybell; Teresa Valencia; Beatriz Herrera; Siouxsie Wiles; Jon S Friedland; Robert H Gilman; Carlton A Evans
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

3.  Investments in tuberculosis research - what are the gaps?

Authors:  Mishal S Khan; Helen Fletcher; Richard Coker
Journal:  BMC Med       Date:  2016-08-25       Impact factor: 8.775

4.  Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India.

Authors:  Asma Munir; Narender Kumar; Suresh Babu Ramalingam; Sembulingam Tamilzhalagan; Siva Kumar Shanmugam; Alangudi Natarajan Palaniappan; Dina Nair; Padma Priyadarshini; Mohan Natarajan; Srikanth Tripathy; Uma Devi Ranganathan; Sharon J Peacock; Julian Parkhill; Tom L Blundell; Sony Malhotra
Journal:  Sci Rep       Date:  2019-07-16       Impact factor: 4.379

5.  Falling Short of the Rights to Health and Scientific Progress: Inadequate TB Drug Research and Access.

Authors:  Mike Frick; Ian Henry; Erica Lessem
Journal:  Health Hum Rights       Date:  2016-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.